NEWS

Blue Medora today announces support for two new cloud platforms – Google Cloud and Alibaba Cloud – for BindPlane™, the industry’s first monitoring integration as a service (MIaaS). BindPlane addresses the common challenge most data center operations teams experience – gaining a comprehensive view of what’s going on across their IT ecosystem. BindPlane dramatically expands observability … Continued

BlueWillow Biologics® today announced the issuance of U.S. patent number 9,974,844, entitled “Cancer Vaccine Compositions And Methods Of Using The Same,” to the University of Michigan under exclusive license to BlueWillow. The patent allows for the use of BlueWillow’s NanoVax® platform with tumor antigens, including neoantigens, to create novel therapeutic vaccines that have the potential … Continued

NanoBio Corporation, a clinical-stage biopharmaceutical company, today announced that it has changed its corporate name to BlueWillow Biologics® in conjunction with the closing of a $10 million Series A financing. The company’s new name reflects its evolution to a vaccines-focused company, and commitment to advancing its novel intranasal technology to develop new vaccines for several … Continued

VNN, America’s largest and fastest growing high school sports communication platform, announced today a partnership with Utah-based Register My Athlete, an innovative provider of digital athlete registration, coach management, and injury tracking software. The collaboration, part of a joint commitment to an open future in high school athletics, makes participating in sports easy for parents … Continued

Enterprise software veteran Doug Dennerline was named BetterWorks Executive Chairman of the Board in November 2017, and now adds CEO to his title. Dennerline brings deep experience leading high-growth enterprise software companies and businesses including Alfresco, SuccessFactors, Salesforce and the Collaboration group at Cisco Systems. “As soon as I joined BetterWorks as its Executive Chairman … Continued

Blue Medora today announces a new service, BindPlane – a major step in delivering IT monitoring integration as a service and a standardized approach to enterprise monitoring integration. Blue Medora is an innovator in monitoring integration software for the most common application performance, cloud and database management platforms. BindPlane is a first-of-its-kind monitoring integration service … Continued

Blue Medora today announces it has closed on an $8 million Series B1 financing round led by First Analysis, a Chicago-based venture capital (VC) firm. Blue Medora is a leading innovator in integration software for the most common application performance management, cloud management and database management platforms. First Analysis will be assuming a seat on … Continued

Oak Ridge National Laboratory (ORNL) is frequently covered by 3D Printing Industry. We’ve reported on projects such as the first 3D printed submarine hull, record-breaking BAAM machines and even a drug-sniffing 3D printed moth.  I spoke to Dr. Niyanth Sridharan – a Postdoctoral researcher in the Material Science and Technology Division at Oak Ridge National … Continued

Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced today that the SoftVue™ Discover Breast Ultrasound Prospective Case Collection project has launched, enrolling the first patient. Qualified participants will undergo screening digital mammography as well as SoftVue 3D whole breast ultrasound exams. Information gathered from the project will compare SoftVue imaging to digital mammography to determine … Continued

NanoBio Corporation today announced the progression of a novel intranasal anthrax vaccine into a pre-clinical IND-enabling toxicology study funded by the U.S. National Institute of Health’s National Institute of Allergy and Infectious Diseases (NIAID). The vaccine combines NanoBio’s novel intranasal nanoemulsion (NE) adjuvant with recombinant protective antigen (rPA) for anthrax from Porton Biopharma Ltd (PBL). Following the pre-clinical … Continued